Immunocytokine
Showing 1 - 25 of 34
Cancer Of Prostate Trial run by the National Cancer Institute (NCI) (M9241, Stereotactic Body Radiation Therapy (SBRT))
Recruiting
- Cancer Of Prostate
- M9241
- Stereotactic Body Radiation Therapy (SBRT)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Histologically or Cytologically Confirmed Pancreatic Cancer, Unresectable or Borderline Resectable Pancreatic Cancer, Pancreatic
Terminated
- Histologically or Cytologically Confirmed Pancreatic Cancer
- +4 more
- M7824
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 19, 2022
Breast Carcinoma, Colorectal Carcinoma Trial in Duarte (procedure, drug, radiation)
Not yet recruiting
- Breast Carcinoma
- Colorectal Carcinoma
- Biopsy
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 8, 2023
Melanoma Trial in Madison (hu14.18-IL2, Radiation Therapy, Nivolumab)
Suspended
- Melanoma
- hu14.18-IL2
- +3 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Jan 3, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Adenocarcinoma, Metastatic Breast Carcinoma Trial in
Withdrawn
- Anatomic Stage IV Breast Cancer AJCC v8
- +4 more
- Bintrafusp Alfa
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 2, 2022
B-cell Non-Hodgkin Lymphoma Trial in Duarte, Minneapolis, Lebanon (DI-Leu16-IL2)
Terminated
- B-cell Non-Hodgkin Lymphoma
-
Duarte, California
- +2 more
Nov 2, 2020
B-cell Non-Hodgkin Lymphoma Trial in United States (DI-Leu16-IL2)
Terminated
- B-cell Non-Hodgkin Lymphoma
-
Duarte, California
- +4 more
Nov 2, 2020
Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers Trial in Worldwide (simlukafusp alfa, Atezolizumab
Completed
- Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers
- simlukafusp alfa
- +3 more
-
San Francisco, California
- +43 more
Feb 18, 2022
Cervical Cancer, HPV Cancers, Anal Cancer Trial run by the NCI (PDS0101, M7824, NHS-IL12)
Active, not recruiting
- Cervical Cancer
- +4 more
- PDS0101
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
Cancer Of Prostate, Prostate Tumors Trial run by the National Cancer Institute (NCI) (ADT, Prednisone, M7824)
Recruiting
- Cancer Of Prostate
- Prostate Neoplasms
- ADT
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Urothelial Cancer, Bladder Cancer, Genitourinary Cancer Trial run by the NCI (M7824, M9241, Stereotactic body radiation therapy
Recruiting
- Urothelial Cancer
- +4 more
- M7824
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Cancer, Solid Tumor, Metastatic Checkpoint Refractory HPV Associated Malignancies Trial run by the National Cancer Institute
Recruiting
- Cancer
- +3 more
- Bintrafusp Alfa
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 11, 2022
Prostate Cancer, Recurrent Prostate Cancer, PET Positive Trial run by the National Cancer Institute (NCI) (Enzalutamide, M9241)
Not yet recruiting
- Prostate Cancer
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 27, 2023
Solid Tumors Trial in Worldwide (Atezolizumab, Cergutuzumab Amunaleukin)
Completed
- Solid Tumors
- Atezolizumab
- Cergutuzumab Amunaleukin
-
New Haven, Connecticut
- +13 more
Jan 15, 2020
Advanced Solid Tumor, Metastatic Solid Tumor Trial in Seoul (GI-102)
Recruiting
- Advanced Solid Tumor
- Metastatic Solid Tumor
-
Seoul, Korea, Republic of
- +3 more
Apr 20, 2023
Small Bowel Cancers, Colorectal Cancers Trial run by the NCI (CV301, MSB0011359C, N-803)
Recruiting
- Small Bowel Cancers
- Colorectal Cancers
- CV301
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Colorectal Cancer Trial run by the National Cancer
Recruiting
- Metastatic Colorectal Cancer (Mcrc)
- +7 more
- Floxuridine
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Epithelial Tumors, Malignant, Epithelial Tumors, Malignant, Malignant Mesenchymal Tumor Trial run by the NCI (NHS-IL-12)
Completed
- Epithelial Neoplasms, Malignant
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 15, 2021
specific Patient Decision Aid (tPDA) of the ImmunoSABR Phase 2
Not yet recruiting
- NSCLC Stage IV
- +3 more
- Decision tool
- (no location specified)
Oct 21, 2020
NSCLC Stage IV, Metastatic Disease Trial in Worldwide (Darleukin, Radiation)
Recruiting
- NSCLC Stage IV
- Metastatic Disease
- Darleukin
- Radiation
-
Brussel, Belgium
- +14 more
Oct 19, 2020
Urothelial Cancer Trial run by the NCI (Bintrafusp alfa (M7824))
Terminated
- Urothelial Cancer
- Bintrafusp alfa (M7824)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 25, 2022